{"pmid":32438476,"title":"Reply to \"Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital\": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.","text":["Reply to \"Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital\": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.","We have read with great interest the article by Fernandez-Nieto et al. showing histopathological pictures of one of the two biopsied cases from their 24 patients diagnosed of vesicular lesions related to COVID-19.(1) They additionally performed a real-time PCR for SARS-CoV-2 that was negative in four tested cases.(1) Regarding their case histopathological pictures, we agree with their description as we can observe acantholytic cells, some of them with dyskeratotic features or grouped without a clear molding of nucleus but reminiscent of the multinucleated giant cells typically observed in herpetic lesions, a picture that looks to our eyes, most likely as an infrequent entity named pseudoherpetic Grover disease (GD),(2) first described as vesicular GD by Fernandez-Figueras.(3).","Clin Exp Dermatol","Llamas-Velasco, M","Chicharro, P","Rodriguez-Jimenez, P","Martos-Cabrera, L","De Argila, D","Fernandez-Figueras, M","Fraga, J","32438476"],"abstract":["We have read with great interest the article by Fernandez-Nieto et al. showing histopathological pictures of one of the two biopsied cases from their 24 patients diagnosed of vesicular lesions related to COVID-19.(1) They additionally performed a real-time PCR for SARS-CoV-2 that was negative in four tested cases.(1) Regarding their case histopathological pictures, we agree with their description as we can observe acantholytic cells, some of them with dyskeratotic features or grouped without a clear molding of nucleus but reminiscent of the multinucleated giant cells typically observed in herpetic lesions, a picture that looks to our eyes, most likely as an infrequent entity named pseudoherpetic Grover disease (GD),(2) first described as vesicular GD by Fernandez-Figueras.(3)."],"journal":"Clin Exp Dermatol","authors":["Llamas-Velasco, M","Chicharro, P","Rodriguez-Jimenez, P","Martos-Cabrera, L","De Argila, D","Fernandez-Figueras, M","Fraga, J"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438476","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/ced.14305","weight":0,"_version_":1667521393742315520,"score":9.490897,"similar":[{"pmid":32384180,"title":"Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital.","text":["Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital.","Vesicular skin rashes have been associated to the Coronavirus Disease 2019 (COVID-19), but there is little information about this cutaneous manifestation. We designed a prospective observational study of patients diagnosed with COVID-19 and vesicular lesions. Clinical characterization of skin findings was conducted by dermatologists. When possible, histological analysis and detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) in the content of the vesicles was performed. A total of 24 patients were included. A disseminated pattern was found in 18 patients (75%), and a localized pattern was found in 6 patients (25%). The median duration of the skin rash was of 10 days. Out of all, 19 patients (79.2%) presented the skin rash after the onset of COVID-19 symptoms. Histologic examination in two patients was consistent with viral infection, SARS-CoV-2 was not detected in four patients. This monocentric study shows the clinical characteristics of vesicular skin rashes in COVID-19 patients.","Clin Exp Dermatol","Fernandez-Nieto, D","Ortega-Quijano, D","Jimenez-Cauhe, J","Burgos-Blasco, P","de Perosanz-Lobo, D","Suarez-Valle, A","Cortes-Cuevas, J L","Carretero, I","Garcia Del Real, C M","Fernandez-Guarino, M","32384180"],"abstract":["Vesicular skin rashes have been associated to the Coronavirus Disease 2019 (COVID-19), but there is little information about this cutaneous manifestation. We designed a prospective observational study of patients diagnosed with COVID-19 and vesicular lesions. Clinical characterization of skin findings was conducted by dermatologists. When possible, histological analysis and detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) in the content of the vesicles was performed. A total of 24 patients were included. A disseminated pattern was found in 18 patients (75%), and a localized pattern was found in 6 patients (25%). The median duration of the skin rash was of 10 days. Out of all, 19 patients (79.2%) presented the skin rash after the onset of COVID-19 symptoms. Histologic examination in two patients was consistent with viral infection, SARS-CoV-2 was not detected in four patients. This monocentric study shows the clinical characteristics of vesicular skin rashes in COVID-19 patients."],"journal":"Clin Exp Dermatol","authors":["Fernandez-Nieto, D","Ortega-Quijano, D","Jimenez-Cauhe, J","Burgos-Blasco, P","de Perosanz-Lobo, D","Suarez-Valle, A","Cortes-Cuevas, J L","Carretero, I","Garcia Del Real, C M","Fernandez-Guarino, M"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32384180","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/ced.14277","topics":["Diagnosis"],"weight":1,"_version_":1666267276726239232,"score":387.04684},{"pmid":32500642,"title":"Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \"varicella-like\".","text":["Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not \"varicella-like\".","Several articles recently reported a \"varicella-like\" rash in patients with COVID-19 [1,2]. We observed similar cases at our institution. However, although we agree that the clinical picture is original, we reject that \"varicella-like\" denomination since clinical presentation, as well as some histologic features that we wish to report here for the first time, make it clearly different from varicella. Three patients with a vesicular rash associated with COVID-19 (RT-PCR test on a nasopharyngeal swab specimen positive for SARS-CoV-2 ARN) were seen at our institution in April, 2020. A biopsy of a vesicle was performed in each. Multiple levels with H&E stain were done; the slides were reviewed independently by two pathologists; only concordant data were validated. A test for SARS-CoV-2 was performed on a vesicle in two patients, and a direct immunofluorescence test on perilesional skin in one.","J Eur Acad Dermatol Venereol","Mahe, A","Birckel, E","Merklen, C","Lefebvre, P","Hannedouche, C","Jost, M","Droy-Dupre, L","32500642"],"abstract":["Several articles recently reported a \"varicella-like\" rash in patients with COVID-19 [1,2]. We observed similar cases at our institution. However, although we agree that the clinical picture is original, we reject that \"varicella-like\" denomination since clinical presentation, as well as some histologic features that we wish to report here for the first time, make it clearly different from varicella. Three patients with a vesicular rash associated with COVID-19 (RT-PCR test on a nasopharyngeal swab specimen positive for SARS-CoV-2 ARN) were seen at our institution in April, 2020. A biopsy of a vesicle was performed in each. Multiple levels with H&E stain were done; the slides were reviewed independently by two pathologists; only concordant data were validated. A test for SARS-CoV-2 was performed on a vesicle in two patients, and a direct immunofluorescence test on perilesional skin in one."],"journal":"J Eur Acad Dermatol Venereol","authors":["Mahe, A","Birckel, E","Merklen, C","Lefebvre, P","Hannedouche, C","Jost, M","Droy-Dupre, L"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500642","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/jdv.16706","keywords":["covid-19","sars-cov-2","acantholysis","coronavirus","skin rash","varicella"],"e_drugs":["Helium"],"topics":["Case Report"],"weight":1,"_version_":1668890966346432512,"score":338.60577},{"pmid":32348545,"title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.","text":["Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.","BACKGROUND: Cutaneous manifestations of COVID-19 disease are poorly characterized. OBJECTIVES: To describe the cutaneous manifestations of COVID-19 disease and to relate them to other clinical findings METHODS: Nationwide case collection survey of images and clinical data. Using a consensus, we described 5 clinical patterns. We later described the association of these patterns with patient demographics, timing in relation to symptoms of the disease, severity, and prognosis. RESULTS: Lesions may be classified as acral areas of erythema with vesicles or pustules (Pseudo-chilblain) (19%), other vesicular eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%) and livedo or necrosis (6%). Vesicular eruptions appear early in the course of the disease (15% before other symptoms). The pseudo-chilblain pattern frequently appears late in the evolution of the COVID-19 disease (59% after other symptoms), while the rest tend to appear with other symptoms of COVID-19. Severity of COVID-19 shows a gradient from less severe disease in acral lesions to most severe in the latter groups. Results are similar for confirmed and suspected cases, both in terms of clinical and epidemiological findings. Alternative diagnoses are discussed but seem unlikely for the most specific patterns (pseudo-chilblain and vesicular). CONCLUSIONS: We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize paucisymptomatic cases.","Br J Dermatol","Galvan Casas, C","Catala, A","Carretero Hernandez, G","Rodriguez-Jimenez, P","Fernandez Nieto, D","Rodriguez-Villa Lario, A","Navarro Fernandez, I","Ruiz-Villaverde, R","Falkenhain, D","Llamas Velasco, M","Garcia-Gavin, J","Baniandres, O","Gonzalez-Cruz, C","Morillas-Lahuerta, V","Cubiro, X","Figueras Nart, I","Selda-Enriquez, G","Romani, J","Fusta-Novell, X","Melian-Olivera, A","Roncero Riesco, M","Burgos-Blasco, P","Sola Ortigosa, J","Feito Rodriguez, M","Garcia-Doval, I","32348545"],"abstract":["BACKGROUND: Cutaneous manifestations of COVID-19 disease are poorly characterized. OBJECTIVES: To describe the cutaneous manifestations of COVID-19 disease and to relate them to other clinical findings METHODS: Nationwide case collection survey of images and clinical data. Using a consensus, we described 5 clinical patterns. We later described the association of these patterns with patient demographics, timing in relation to symptoms of the disease, severity, and prognosis. RESULTS: Lesions may be classified as acral areas of erythema with vesicles or pustules (Pseudo-chilblain) (19%), other vesicular eruptions (9%), urticarial lesions (19%), maculopapular eruptions (47%) and livedo or necrosis (6%). Vesicular eruptions appear early in the course of the disease (15% before other symptoms). The pseudo-chilblain pattern frequently appears late in the evolution of the COVID-19 disease (59% after other symptoms), while the rest tend to appear with other symptoms of COVID-19. Severity of COVID-19 shows a gradient from less severe disease in acral lesions to most severe in the latter groups. Results are similar for confirmed and suspected cases, both in terms of clinical and epidemiological findings. Alternative diagnoses are discussed but seem unlikely for the most specific patterns (pseudo-chilblain and vesicular). CONCLUSIONS: We provide a description of the cutaneous manifestations associated with COVID-19 infection. These may help clinicians approach patients with the disease and recognize paucisymptomatic cases."],"journal":"Br J Dermatol","authors":["Galvan Casas, C","Catala, A","Carretero Hernandez, G","Rodriguez-Jimenez, P","Fernandez Nieto, D","Rodriguez-Villa Lario, A","Navarro Fernandez, I","Ruiz-Villaverde, R","Falkenhain, D","Llamas Velasco, M","Garcia-Gavin, J","Baniandres, O","Gonzalez-Cruz, C","Morillas-Lahuerta, V","Cubiro, X","Figueras Nart, I","Selda-Enriquez, G","Romani, J","Fusta-Novell, X","Melian-Olivera, A","Roncero Riesco, M","Burgos-Blasco, P","Sola Ortigosa, J","Feito Rodriguez, M","Garcia-Doval, I"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348545","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/bjd.19163","keywords":["covid-19","skin manifestations","diagnosis"],"locations":["Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Diagnosis"],"weight":1,"_version_":1666138495413911552,"score":212.50853},{"pmid":32502585,"pmcid":"PMC7265862","title":"CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC (\"COVID TOES\"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES.","text":["CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC (\"COVID TOES\"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES.","BACKGROUND: During the COVID-19 pandemic, several acral chilblain-like skin lesions (CBLL) were observed in young patients with suspected, but mostly unconfirmed, infection with SARS-CoV-2. The histopathological aspect of these lesions is as yet poorly known. OBJECTIVE: To investigate the pathologic features of CBLL. METHODS: Biopsies were obtained from 17 cases of CBLL during the COVID-19 pandemic in France and were studied by routine histological examination, immunohistochemistry and direct immunofluorescence (DIF). The patients had suspected but unconfirmed infection with SARS-CoV-2 (negative nasopharyngeal PCR test and serological tests). RESULTS: CBLL showed many features with those reported in idiopathic (IC) and auto-immune related chilblains (AC), including epidermal necrotic keratinocytes, dermal edema, perivascular and perieccrine sweat gland lymphocytic (predominantly CD3/CD4+) inflammation and frequent vascular changes (endothelialitis, microthromboses, fibrin deposition, immunoreactant deposits on vessels). CONCLUSIONS: CBLL show similar histopathologic features with IC and AC, with a rather high rate of vascular changes and DIF positivity. The role of SARS-CoV-2 in the development of these puzzling lesions remains to be elucidated.","J Am Acad Dermatol","Kanitakis, Jean","Lesort, Cecile","Danset, Marie","Jullien, Denis","32502585"],"abstract":["BACKGROUND: During the COVID-19 pandemic, several acral chilblain-like skin lesions (CBLL) were observed in young patients with suspected, but mostly unconfirmed, infection with SARS-CoV-2. The histopathological aspect of these lesions is as yet poorly known. OBJECTIVE: To investigate the pathologic features of CBLL. METHODS: Biopsies were obtained from 17 cases of CBLL during the COVID-19 pandemic in France and were studied by routine histological examination, immunohistochemistry and direct immunofluorescence (DIF). The patients had suspected but unconfirmed infection with SARS-CoV-2 (negative nasopharyngeal PCR test and serological tests). RESULTS: CBLL showed many features with those reported in idiopathic (IC) and auto-immune related chilblains (AC), including epidermal necrotic keratinocytes, dermal edema, perivascular and perieccrine sweat gland lymphocytic (predominantly CD3/CD4+) inflammation and frequent vascular changes (endothelialitis, microthromboses, fibrin deposition, immunoreactant deposits on vessels). CONCLUSIONS: CBLL show similar histopathologic features with IC and AC, with a rather high rate of vascular changes and DIF positivity. The role of SARS-CoV-2 in the development of these puzzling lesions remains to be elucidated."],"journal":"J Am Acad Dermatol","authors":["Kanitakis, Jean","Lesort, Cecile","Danset, Marie","Jullien, Denis"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502585","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jaad.2020.05.145","keywords":["covid-19","sars-cov-2","chilblains","dermatopathology","direct immunofluorescence","eosinophils","immunohistochemistry"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Diagnosis"],"weight":1,"_version_":1668890966382084096,"score":211.18015},{"pmid":32410386,"title":"Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.","text":["Smell and taste alterations in Covid-19: a cross-sectional analysis of different cohorts.","BACKGROUND: Olfactory (OD) and gustatory (GD) dysfunction have been proven to be a typical symptom of SARS-CoV-2 infection. However, their prevalence in different patient populations still needs to be clarified. METHODS: A cross-sectional study was performed from March 27 to April 1 2020 in Northern Italy. Physicians administered a survey-based questionnaire to SARS-CoV-2 positive patients with the aim of assessing symptoms, focusing on OD and GD. Two groups were studied: patients hospitalized at ASST Spedali Civili University Hospital of Brescia (A); home-quarantined subjects (B). RESULTS: A total of 508 patients were enrolled: 295 in Group A and 213 in Group B. Mean age (+/-SD) was 55+/-15 years; 56% were men. Overall, OD and GD were present in 56% (95% CI 51-60%) and 63% (59-67%) of cases, respectively. In Group A, the prevalence of OD and GD was 44% (38-50%) and 52% (46-58%). In Group B, the prevalence of OD and GD was 72% (65-79%) and 79% (73-84%). In the entire cohort, total loss of olfaction and taste was reported in 64% and 60% of cases, respectively. OD and GD occurred as the first symptom in 10% and 11% of cases; in the remaining cases, they occurred after a mean of 4+/-3 days following the first symptom. At the time of the questionnaire, complete resolution of OD and GD was reported in 52% and 55% of cases (mean duration: 9+/-5 in both). CONCLUSIONS: OD and GD are more prevalent in home-quarantined subjects, and they are independently associated with younger age and female gender. This article is protected by copyright. All rights reserved.","Int Forum Allergy Rhinol","Paderno, Alberto","Schreiber, Alberto","Grammatica, Alberto","Raffetti, Elena","Tomasoni, Michele","Gualtieri, Tommaso","Taboni, Stefano","Zorzi, Silvia","Lombardi, Davide","Deganello, Alberto","Redaelli De Zinis, Luca Oscar","Maroldi, Roberto","Mattavelli, Davide","32410386"],"abstract":["BACKGROUND: Olfactory (OD) and gustatory (GD) dysfunction have been proven to be a typical symptom of SARS-CoV-2 infection. However, their prevalence in different patient populations still needs to be clarified. METHODS: A cross-sectional study was performed from March 27 to April 1 2020 in Northern Italy. Physicians administered a survey-based questionnaire to SARS-CoV-2 positive patients with the aim of assessing symptoms, focusing on OD and GD. Two groups were studied: patients hospitalized at ASST Spedali Civili University Hospital of Brescia (A); home-quarantined subjects (B). RESULTS: A total of 508 patients were enrolled: 295 in Group A and 213 in Group B. Mean age (+/-SD) was 55+/-15 years; 56% were men. Overall, OD and GD were present in 56% (95% CI 51-60%) and 63% (59-67%) of cases, respectively. In Group A, the prevalence of OD and GD was 44% (38-50%) and 52% (46-58%). In Group B, the prevalence of OD and GD was 72% (65-79%) and 79% (73-84%). In the entire cohort, total loss of olfaction and taste was reported in 64% and 60% of cases, respectively. OD and GD occurred as the first symptom in 10% and 11% of cases; in the remaining cases, they occurred after a mean of 4+/-3 days following the first symptom. At the time of the questionnaire, complete resolution of OD and GD was reported in 52% and 55% of cases (mean duration: 9+/-5 in both). CONCLUSIONS: OD and GD are more prevalent in home-quarantined subjects, and they are independently associated with younger age and female gender. This article is protected by copyright. All rights reserved."],"journal":"Int Forum Allergy Rhinol","authors":["Paderno, Alberto","Schreiber, Alberto","Grammatica, Alberto","Raffetti, Elena","Tomasoni, Michele","Gualtieri, Tommaso","Taboni, Stefano","Zorzi, Silvia","Lombardi, Davide","Deganello, Alberto","Redaelli De Zinis, Luca Oscar","Maroldi, Roberto","Mattavelli, Davide"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32410386","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1002/alr.22610","keywords":["covid-19","sars-cov-2","gustatory dysfunction","olfactory dysfunction","smell","taste"],"locations":["Physicians","Brescia"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666897319200555008,"score":198.89713}]}